Small size, big impact

31 October 2023 by

Small molecule drugs have stood the test of time as the preeminent pharmaceutical method for treating patients. What this also means is that competition in the space is fierce, and every advantage matters – both in terms of manufacturing costs and product performance. Bill McCarthy, director of marketing at SPI Pharma, explains how the company’s S-Tab tablet platform offers both of these advantages, as well as enabling companies to bring products to market and scale them faster.

Available Downloads

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.